Among them, FSTL1 has been proved to promote the progression of focal segmental glomerular sclerosis(FSGS), membranous nephropathy (MN), immunoglobulin A (IgA) nephropathy (IgAN), and other chronic kidney diseases. Here, FSTL1 is linked to membranous glomerulonephritis.